Health Catalyst, Inc. (HCAT)
1.745
+0.04
(+2.65%)
USD |
NASDAQ |
Sep 14, 10:38
Health Catalyst Enterprise Value : 193.36M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 193.36M |
| September 10, 2026 | 195.59M |
| September 09, 2026 | 195.59M |
| September 08, 2026 | 193.36M |
| September 04, 2026 | 192.61M |
| September 03, 2026 | 194.10M |
| September 02, 2026 | 192.61M |
| September 01, 2026 | 194.10M |
| August 31, 2026 | 188.88M |
| August 28, 2026 | 185.15M |
| August 27, 2026 | 185.15M |
| August 26, 2026 | 185.15M |
| August 25, 2026 | 184.40M |
| August 24, 2026 | 185.15M |
| August 21, 2026 | 180.67M |
| August 20, 2026 | 188.13M |
| August 19, 2026 | 192.61M |
| August 18, 2026 | 194.10M |
| August 17, 2026 | 193.36M |
| August 14, 2026 | 204.55M |
| August 13, 2026 | 197.09M |
| August 12, 2026 | 200.07M |
| August 11, 2026 | 197.83M |
| August 10, 2026 | 194.85M |
| August 07, 2026 | 195.59M |
| Date | Value |
|---|---|
| August 06, 2026 | 238.86M |
| August 05, 2026 | 244.83M |
| August 04, 2026 | 236.62M |
| August 03, 2026 | 231.40M |
| July 31, 2026 | 222.45M |
| July 30, 2026 | 221.70M |
| July 29, 2026 | 227.67M |
| July 28, 2026 | 226.18M |
| July 27, 2026 | 226.92M |
| July 24, 2026 | 221.70M |
| July 23, 2026 | 216.48M |
| July 22, 2026 | 218.72M |
| July 21, 2026 | 223.19M |
| July 20, 2026 | 227.67M |
| July 17, 2026 | 234.38M |
| July 16, 2026 | 236.62M |
| July 15, 2026 | 240.35M |
| July 14, 2026 | 237.37M |
| July 13, 2026 | 237.37M |
| July 10, 2026 | 237.37M |
| July 09, 2026 | 233.64M |
| July 08, 2026 | 230.65M |
| July 07, 2026 | 235.88M |
| July 06, 2026 | 237.37M |
| July 02, 2026 | 221.70M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| LataMed AI Corp. | 69.14M |
| SCWorx Corp. | -0.9956M |
| GoodRx Holdings, Inc. | 1.396B |
| Claritev Corp. | 5.280B |
| iSpecimen, Inc. | -1.936M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -40.54M |
| Revenue (Quarterly) | 70.49M |
| Total Expenses (Quarterly) | 111.02M |
| EPS Diluted (Quarterly) | -0.5481 |
| Gross Profit Margin (Quarterly) | 34.67% |
| Profit Margin (Quarterly) | -57.51% |
| Earnings Yield | -210.6% |
| Normalized Earnings Yield | -91.86 |